HALO Barretts Ablation
Barrett's esophagus tissue is very thin and is therefore a good candidate for removal with ablative engery. Delivery of ablative energy with the HALO ablation technology is therefore capable of achieving complete removal of the diseased tissue without damage to the normal underlying structures.
Clinical studies have demonstrated the Barrett's tissue can be completely eliminated with the HALO ablation technology in 98.4% of patients.
What happens during treatment with the HALO ablation technology?
Ablation therapy is performed in conjunction with upper endoscopy. The treatment is performed in an outpatient setting and no incisions are involved. The HALO ablation technology consist of two different devices: HALO360 and HALO90 ablation catheters. The HALO360 ablation catheter is capable of treating the larger areas of circcumferential Barrett's esophagus, while the HALO90 ablation catheter is used to treat smaller areas.
What to expect after treatment?
Patients may experience some chest discomfort and difficulty swallowing for several days after the procedure, both of which are managed with medications provided by the physician. In clinical trials, these symptoms typically resolved within 3-4 days. Patients are provided with anti-acid medications to promote healing of the treated esophagus and replacement of the diseased Barrett's tissue with a normal, healthy esophagus lining.
A follow-up appointment is scheduled within 2-3 months to assess the response to treatment. If there remains any residual Barrett's tissue, additional therapy may be recommended.
How is GERD managed after a successful ablation?
Successful elimination of the Barrett's esophagus tissue does not cure pre-existing GERD or the associated symptoms. The physician will guide the patient regarding long-term GERD therapy.